Literature DB >> 2790679

DNA cytofluorometric and nuclear morphometric analyses of lung adenocarcinoma.

H Asamura1, T Nakajima, K Mukai, M Noguchi, Y Shimosato.   

Abstract

The nuclear DNA content of tumor cells in imprint smears prepared from 72 surgically resected adenocarcinomas of the lung was determined prospectively by means of cytofluorometry, and its relationship to pathologic stage, degree of histologic differentiation, and nuclear atypia represented by the mean nuclear area (MNA) and standard deviation of the nuclear area (SDNA) was studied. The mean nuclear DNA content (MNDC) of poorly differentiated adenocarcinomas was significantly larger than that of well-differentiated adenocarcinomas both in Stages I + II and III + IV (P less than 0.001, each), and the MNDC of Stages III + IV was significantly larger than that of I + II in poorly differentiated adenocarcinomas (P less than 0.01). There was a tendency for histogram Patterns III and IV, in which more aneuploid cells were present than in I and II, to be more common and for the incidence of the aneuploid stem cell line to be higher in less differentiated and more advanced adenocarcinomas, although the differences were not significant statistically. Furthermore, there were significant positive correlations between MNDC and MNA (P less than 0.01) and between MNDC and SDNA (P less than 0.05). The averages of the MNA according to the histogram pattern increased significantly in the increasing order of Patterns I to IV. These results indicate that the nuclear DNA content increases in less differentiated and more advanced adenocarcinomas, and that the nuclear atypia is reflected in abnormal nuclear DNA content (DNA aneuploidy).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2790679     DOI: 10.1002/1097-0142(19891015)64:8<1657::aid-cncr2820640817>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

Review 1.  How malignant is malignant? A brief review of the microscopic assessment of human neoplasms, and the prediction of whether they will metastasize and kill.

Authors:  I Carr; N Pettigrew
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

2.  The relevance of flow-cytometric DNA content in the evaluation of lung cancer.

Authors:  F Salvati; L Teodori; M L Trinca; R Pasquali-Lasagni; W Göhde
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

3.  Adenocarcinoma of the lung with selective metastasis to the lung: clinical, histologic and DNA-cytofluorometric analyses.

Authors:  H Nomori; Y Matsuno; M Noguchi; S Tsugane; Y Shimosato; S Hirohashi
Journal:  Jpn J Cancer Res       Date:  1992-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.